Anti-Seizure Medication Depakote Tied to Birth Defects

 Posted on April 09,2013 in Birth Defects

In 1983, the FDA approved Depakote to treat certain issues with the central nervous system. It has successfully treated or controlled such disorders as epileptic seizures and episodes of manic or bipolar behavior. This medicine can also be prescribed for migraine headaches. It is primarily used as a mood stabilizer and anti-convulsant, which has also provided relief for certain off label conditions.

After years of tests and research, there have been recent studies that have identified issues with this medication. Unfortunately, this is a far too common, because even the vigorous tests that were run by the FDA can miss potentially fatal side effects. In 2009, the FDA warned pregnant mothers about certain congenital birth defects such as a cleft palate, spina bifida, malformed hands and autism.

Again, in 2011, the FDA notified consumers of other possible side effects. The results of studies by Emory University have given cognitive tests to children from 3 to 6 years old. The results have shown that children of mothers who took Depakote while pregnant tended to score lower on IQ tests than mothers who took other anti-seizure medications during pregnancy.

Women who can get pregnant or are pregnant should be notified of the side effects associated with all drugs they are prescribed. While seizures can also be very dangerous to unborn babies, there should be a disclosure of the possible outcomes. Especially if there is an alternative plan of medication available.

If you or a loved one have been affected by improperly prescribed medication, you may be eligible for damages and suffering. Contact an experienced defective medical attorney in Itasca today.